Sandoz Canada Ranitidine Product Recall (2019-09-17)
- Starting date:
- September 17, 2019
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-71031
Last updated: 2019-09-18
Summary
-
Product:
A. Sandoz Ranitidine 150 mg TabletB. Sandoz Ranitidine 300 mg Tablet
A. Sandoz Ranitidine 150 mg Tablet
B. Sandoz Ranitidine 300 mg Tablet
Reason
Affected lots may be manufactured with an API containing an impurity, N-nitrosodimethylamine (NDMA).
Depth of distribution
Wholesalers, Retailers
Affected products
A. Sandoz Ranitidine 150 mg Tablet
DIN, NPN, DIN-HIM
DIN 02243229
Dosage form
Tablet
Strength
Ranitidine hydrochloride 150 mg
Lot or serial number
All lots
Companies
- Recalling Firm
-
Sandoz Canada Incorporated
110 Rue De Lauzon
Boucherville
J4B 1E6
Quebec
CANADA
- Marketing Authorization Holder
-
Sandoz Canada Incorporated
110 Rue De Lauzon
Boucherville
J4B 1E6
Quebec
CANADA
B. Sandoz Ranitidine 300 mg Tablet
DIN, NPN, DIN-HIM
DIN 02243230
Dosage form
Tablet
Strength
Ranitidine hydrochloride 300 mg
Lot or serial number
All lots
Companies
- Recalling Firm
-
Sandoz Canada Incorporated
110 Rue De Lauzon
Boucherville
J4B 1E6
Quebec
CANADA
- Marketing Authorization Holder
-
Sandoz Canada Incorporated
110 Rue De Lauzon
Boucherville
J4B 1E6
Quebec
CANADA